- Home
- MNSB vs LENZ Comparison
MNSB vs LENZ Comparison
Compare MNSB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | LENZ |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 142.0M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNSB | LENZ |
|---|---|---|
| Price | $25.36 | $4.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 25.0K | ★ 593.2K |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | ★ 210.00 | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $135,615,000.00 | $19,088,000.00 |
| Revenue This Year | $1.50 | $50.42 |
| Revenue Next Year | $3.77 | $197.16 |
| P/E Ratio | $24.06 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.86 | $4.50 |
| 52 Week High | $25.87 | $50.19 |
Technical Indicators
Market Signals| Indicator | MNSB | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 39.29 |
| Support Level | $23.58 | N/A |
| Resistance Level | $25.71 | $6.11 |
| Average True Range (ATR) | 0.53 | 0.33 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 60.47 | 3.38 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.